4//SEC Filing
Basile Edward M 4
Accession 0001193125-25-260849
CIK 0001756262other
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 4:30 PM ET
Size
8.6 KB
Accession
0001193125-25-260849
Insider Transaction Report
Form 4
Basile Edward M
Director
Transactions
- Sale
Common Stock
2025-10-29$130.45/sh−4,142$540,324→ 2,866 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-10-29−4,142→ 0 totalExercise: $0.70Exp: 2026-02-16→ Common Stock (4,142 underlying) - Exercise/Conversion
Common Stock
2025-10-29$0.70/sh+4,142$2,899→ 7,008 total
Footnotes (3)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on November 6, 2024.
- [F2]The option is fully vested.
- [F3]The Stock Option reported herein as being disposed of is an option to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.
Documents
Issuer
TransMedics Group, Inc.
CIK 0001756262
Entity typeother
Related Parties
1- filerCIK 0001773661
Filing Metadata
- Form type
- 4
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 4:30 PM ET
- Size
- 8.6 KB